Latest Kynam Capital Management, LP Stock Portfolio
$1.30Billion– No. of Holdings #22
Kynam Capital Management, LP Performance:
2024 Q2: -1.77%YTD: 21.21%2023: 4.66%
Performance for 2024 Q2 is -1.77%, and YTD is 21.21%, and 2023 is 4.66%.
About Kynam Capital Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Kynam Capital Management, LP reported an equity portfolio of $1.3 Billions as of 30 Jun, 2024.
The top stock holdings of Kynam Capital Management, LP are NTRA, CLDX, SNDX. The fund has invested 16.8% of it's portfolio in NATERA INC and 9.7% of portfolio in CELLDEX THERAPEUTICS INC NEW.
The fund managers got completely rid off BURNING ROCK BIOTECH LTD (BNR) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA) and PROTAGONIST THERAPEUTICS INC (PTGX). Kynam Capital Management, LP opened new stock positions in BURNING ROCK BIOTECH LTD (BNR) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), ACELYRIN INC and DYNAVAX TECHNOLOGIES CORP (DVAX).
The top stock holdings of Kynam Capital Management, LP are NTRA, CLDX, SNDX. The fund has invested 16.8% of it's portfolio in NATERA INC and 9.7% of portfolio in CELLDEX THERAPEUTICS INC NEW.
The fund managers got completely rid off BURNING ROCK BIOTECH LTD (BNR) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA) and PROTAGONIST THERAPEUTICS INC (PTGX). Kynam Capital Management, LP opened new stock positions in BURNING ROCK BIOTECH LTD (BNR) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), ACELYRIN INC and DYNAVAX TECHNOLOGIES CORP (DVAX).
Kynam Capital Management, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Kynam Capital Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Kynam Capital Management, LP made a return of -1.77% in the last quarter. In trailing 12 months, it's portfolio return was 25.84%.
New Buys
| Ticker | $ Bought |
|---|---|
| burning rock biotech ltd | 6,283,880 |
| cg oncology inc | 1,701,970 |
New stocks bought by Kynam Capital Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| viridian therapeutics inc | 1,207 |
| acelyrin inc | 109 |
| dynavax technologies corp | 67.05 |
| caribou biosciences inc | 54.11 |
| biocryst pharmaceuticals inc | 35.22 |
| celldex therapeutics inc new | 16.86 |
| tyra biosciences inc | 10.00 |
| cogent biosciences inc | 8.95 |
Additions to existing portfolio by Kynam Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| liquidia corporation | -59.23 |
| protagonist therapeutics inc | -30.08 |
Kynam Capital Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| burning rock biotech ltd | -7,019,550 |
Kynam Capital Management, LP got rid off the above stocks
Sector Distribution
Kynam Capital Management, LP has about 98.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 98.8 |
| Others | 1.2 |
Market Cap. Distribution
Kynam Capital Management, LP has about 22.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 43.9 |
| MID-CAP | 27.8 |
| LARGE-CAP | 22.8 |
| MICRO-CAP | 4.2 |
| UNALLOCATED | 1.2 |
Stocks belong to which Index?
About 75.1% of the stocks held by Kynam Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 75.1 |
| Others | 24.9 |
Kynam Capital Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Kynam Capital Management, LP
Kynam Capital Management, LP has 22 stocks in it's portfolio. About 64.5% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Kynam Capital Management, LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMRN | amarin corp plc | 0.64 | 12,155,800 | 8,363,210 | added | 1.11 | ||
| BCRX | biocryst pharmaceuticals inc | 4.21 | 8,826,710 | 54,549,100 | added | 35.22 | ||
| BNR | burning rock biotech ltd | 0.48 | 974,668 | 6,283,880 | new | |||
| BNR | burning rock biotech ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 9.68 | 3,388,970 | 125,426,000 | added | 16.86 | ||
| COGT | cogent biosciences inc | 6.02 | 9,260,380 | 78,065,000 | added | 8.95 | ||
| CRBU | caribou biosciences inc | 0.21 | 1,646,700 | 2,700,590 | added | 54.11 | ||
| DVAX | dynavax technologies corp | 6.14 | 7,082,560 | 79,537,200 | added | 67.05 | ||
| IRWD | ironwood pharmaceuticals inc | 0.83 | 1,641,890 | 10,705,100 | added | 1.04 | ||
| LQDA | liquidia corporation | 0.85 | 916,574 | 10,998,900 | reduced | -59.23 | ||
| NTRA | natera inc | 16.83 | 2,014,410 | 218,140,000 | added | 0.72 | ||
| PCVX | vaxcyte inc | 4.39 | 753,240 | 56,877,200 | added | 1.11 | ||
| PTGX | protagonist therapeutics inc | 2.14 | 800,000 | 27,720,000 | reduced | -30.08 | ||
| SNDX | syndax pharmaceuticals inc | 9.06 | 5,722,060 | 117,474,000 | added | 1.1 | ||
| STRO | sutro biopharma inc | 0.46 | 2,023,680 | 5,929,390 | added | 1.1 | ||
| TSVT | 2seventy bio inc | 1.77 | 5,953,820 | 22,922,200 | unchanged | 0.00 | ||
| TVTX | travere therapeutics inc | 1.28 | 2,021,660 | 16,618,000 | added | 1.08 | ||
| TYRA | tyra biosciences inc | 0.70 | 566,715 | 9,061,770 | added | 10.00 | ||
| VERA | vera therapeutics inc | 4.31 | 1,543,670 | 55,849,900 | added | 1.11 | ||
| VRDN | viridian therapeutics inc | 1.76 | 1,750,000 | 22,767,500 | added | 1,207 | ||